Funder: Breakthrough T1D
Due Dates: November 12, 2025 (LOI) | January 21, 2026 (Full proposal)
Funding Amounts: Up to $1,500,000 total over 3 years; typical awards may be smaller; indirect costs up to 10% allowed for nonprofits.
Summary: Supports research on clinically relevant questions about ketones and continuous ketone monitoring to advance understanding and care in type 1 diabetes.
Key Information: LOI approval required before full proposal; for-profit applicants must provide matching funds and meet additional requirements.